CRF serum levels differentiate PTSD from healthy controls and TBI in military veterans
Background and Objective Posttraumatic stress disorder (PTSD) is a serious and frequently debilitating psychiatric condition that can occur in people who have experienced traumatic stressors, such as war, violence, sexual assault and other life‐threatening events. Treatment of PTSD and traumatic bra...
Guardado en:
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1c4afccd41ed4a41b4c2238e08b813fd |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:1c4afccd41ed4a41b4c2238e08b813fd |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:1c4afccd41ed4a41b4c2238e08b813fd2021-12-02T13:52:49ZCRF serum levels differentiate PTSD from healthy controls and TBI in military veterans2575-560910.1176/appi.prcp.20210017https://doaj.org/article/1c4afccd41ed4a41b4c2238e08b813fd2021-12-01T00:00:00Zhttps://doi.org/10.1176/appi.prcp.20210017https://doaj.org/toc/2575-5609Background and Objective Posttraumatic stress disorder (PTSD) is a serious and frequently debilitating psychiatric condition that can occur in people who have experienced traumatic stressors, such as war, violence, sexual assault and other life‐threatening events. Treatment of PTSD and traumatic brain injury (TBI) in veterans is challenged by diagnostic complexity, partially due to PTSD and TBI symptoms overlap and to the fact that subjective self‐report assessments may be influenced by a patient's willingness to share their traumatic experiences and resulting symptoms. Corticotropin‐releasing factor (CRF) is one of the main mediators of hypothalamic pituitary adrenal (HPA)‐axis responses in stress and anxiety. Methods and Results We analyzed serum CRF levels in 230 participants including heathy controls (64), and individuals with PTSD (53), TBI (70) or PTSD + TBI (43) by enzyme immunoassay (EIA). Significantly lower CRF levels were found in both the PTSD and PTSD + TBI groups compared to healthy control (PTSD vs. Controls: P = 0.0014, PTSD + TBI vs. Controls: P = 0.0011) and chronic TBI participants (PTSD vs. TBI: P < 0.0001, PTSD + TBI vs. TBI: P < 0.0001), suggesting a PTSD‐related mechanism independent from TBI and associated with CRF reduction. CRF levels negatively correlated with PTSD severity on the Clinically Administered PTSD Scale (CAPS‐5) scale in the whole study group. Conclusions Hyperactivation of the HPA axis has been classically identified in acute stress. However, the recognized enhanced feedback inhibition of the HPA axis in chronic stress supports our findings of lower CRF in PTSD patients. This study suggests that reduced serum CRF in PTSD should be further investigated. Future validation studies will establish if CRF is a possible blood biomarker for PTSD and/or for differentiating PTSD and chronic TBI symptomatology.Jaime Ramos‐CejudoAfia GenfiDuna Abu‐AmaraLudovic DebureMeng QianEugene LaskaCarole SiegelNicholas MiltonJennifer NewmanEsther BlessingMeng LiAmit EtkinCharles R. MarmarSilvia FossatiWileyarticlePsychiatryRC435-571ENPsychiatric Research and Clinical Practice, Vol 3, Iss 4, Pp 153-162 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Psychiatry RC435-571 |
spellingShingle |
Psychiatry RC435-571 Jaime Ramos‐Cejudo Afia Genfi Duna Abu‐Amara Ludovic Debure Meng Qian Eugene Laska Carole Siegel Nicholas Milton Jennifer Newman Esther Blessing Meng Li Amit Etkin Charles R. Marmar Silvia Fossati CRF serum levels differentiate PTSD from healthy controls and TBI in military veterans |
description |
Background and Objective Posttraumatic stress disorder (PTSD) is a serious and frequently debilitating psychiatric condition that can occur in people who have experienced traumatic stressors, such as war, violence, sexual assault and other life‐threatening events. Treatment of PTSD and traumatic brain injury (TBI) in veterans is challenged by diagnostic complexity, partially due to PTSD and TBI symptoms overlap and to the fact that subjective self‐report assessments may be influenced by a patient's willingness to share their traumatic experiences and resulting symptoms. Corticotropin‐releasing factor (CRF) is one of the main mediators of hypothalamic pituitary adrenal (HPA)‐axis responses in stress and anxiety. Methods and Results We analyzed serum CRF levels in 230 participants including heathy controls (64), and individuals with PTSD (53), TBI (70) or PTSD + TBI (43) by enzyme immunoassay (EIA). Significantly lower CRF levels were found in both the PTSD and PTSD + TBI groups compared to healthy control (PTSD vs. Controls: P = 0.0014, PTSD + TBI vs. Controls: P = 0.0011) and chronic TBI participants (PTSD vs. TBI: P < 0.0001, PTSD + TBI vs. TBI: P < 0.0001), suggesting a PTSD‐related mechanism independent from TBI and associated with CRF reduction. CRF levels negatively correlated with PTSD severity on the Clinically Administered PTSD Scale (CAPS‐5) scale in the whole study group. Conclusions Hyperactivation of the HPA axis has been classically identified in acute stress. However, the recognized enhanced feedback inhibition of the HPA axis in chronic stress supports our findings of lower CRF in PTSD patients. This study suggests that reduced serum CRF in PTSD should be further investigated. Future validation studies will establish if CRF is a possible blood biomarker for PTSD and/or for differentiating PTSD and chronic TBI symptomatology. |
format |
article |
author |
Jaime Ramos‐Cejudo Afia Genfi Duna Abu‐Amara Ludovic Debure Meng Qian Eugene Laska Carole Siegel Nicholas Milton Jennifer Newman Esther Blessing Meng Li Amit Etkin Charles R. Marmar Silvia Fossati |
author_facet |
Jaime Ramos‐Cejudo Afia Genfi Duna Abu‐Amara Ludovic Debure Meng Qian Eugene Laska Carole Siegel Nicholas Milton Jennifer Newman Esther Blessing Meng Li Amit Etkin Charles R. Marmar Silvia Fossati |
author_sort |
Jaime Ramos‐Cejudo |
title |
CRF serum levels differentiate PTSD from healthy controls and TBI in military veterans |
title_short |
CRF serum levels differentiate PTSD from healthy controls and TBI in military veterans |
title_full |
CRF serum levels differentiate PTSD from healthy controls and TBI in military veterans |
title_fullStr |
CRF serum levels differentiate PTSD from healthy controls and TBI in military veterans |
title_full_unstemmed |
CRF serum levels differentiate PTSD from healthy controls and TBI in military veterans |
title_sort |
crf serum levels differentiate ptsd from healthy controls and tbi in military veterans |
publisher |
Wiley |
publishDate |
2021 |
url |
https://doaj.org/article/1c4afccd41ed4a41b4c2238e08b813fd |
work_keys_str_mv |
AT jaimeramoscejudo crfserumlevelsdifferentiateptsdfromhealthycontrolsandtbiinmilitaryveterans AT afiagenfi crfserumlevelsdifferentiateptsdfromhealthycontrolsandtbiinmilitaryveterans AT dunaabuamara crfserumlevelsdifferentiateptsdfromhealthycontrolsandtbiinmilitaryveterans AT ludovicdebure crfserumlevelsdifferentiateptsdfromhealthycontrolsandtbiinmilitaryveterans AT mengqian crfserumlevelsdifferentiateptsdfromhealthycontrolsandtbiinmilitaryveterans AT eugenelaska crfserumlevelsdifferentiateptsdfromhealthycontrolsandtbiinmilitaryveterans AT carolesiegel crfserumlevelsdifferentiateptsdfromhealthycontrolsandtbiinmilitaryveterans AT nicholasmilton crfserumlevelsdifferentiateptsdfromhealthycontrolsandtbiinmilitaryveterans AT jennifernewman crfserumlevelsdifferentiateptsdfromhealthycontrolsandtbiinmilitaryveterans AT estherblessing crfserumlevelsdifferentiateptsdfromhealthycontrolsandtbiinmilitaryveterans AT mengli crfserumlevelsdifferentiateptsdfromhealthycontrolsandtbiinmilitaryveterans AT amitetkin crfserumlevelsdifferentiateptsdfromhealthycontrolsandtbiinmilitaryveterans AT charlesrmarmar crfserumlevelsdifferentiateptsdfromhealthycontrolsandtbiinmilitaryveterans AT silviafossati crfserumlevelsdifferentiateptsdfromhealthycontrolsandtbiinmilitaryveterans |
_version_ |
1718392366200520704 |